Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome and Epiretinal Membrane or Macular Hole: a Pilot Study

NCT07506551 is registered in ClinicalTrials.gov with Prim. Prof. Dr. Oliver Findl, MBA as lead sponsor.

NCT NCT07506551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07506551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitreous Proteomics of Patients Suffering From Pseudoexfoliation Syndrome and Epiretinal Membrane or Macular Hole: a Pilot Study
Lead sponsor
Prim. Prof. Dr. Oliver Findl, MBA
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 6, 2023
Completion date
December 1, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pseudoexfoliation syndrome